These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13393965)

  • 1. [Use of dihydro-alkaloids of spurred rye as essential constituents of the lytic cocktail in potentiated anesthesia, with special reference to their effect on the cardio-circulatory system].
    DA RIN A
    Acta Anaesthesiol; 1956; 7(5):373-92. PubMed ID: 13393965
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined hydergine and lytic cocktail M1 in potentiated anesthesia].
    DE BONIS B; LEONI L
    Acta Anaesthesiol; 1957; 8(3):243-57. PubMed ID: 13457683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dihydro alkaloids of the ergotoxin group in potentiated anesthesia (neuroplegia & anesthesia); preliminary clinical findings].
    CENTORE F
    Minerva Anestesiol; 1957 Oct; 23(10):286-8. PubMed ID: 13503721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined hydergine and lytic cocktail M1 in potentiated anesthesia].
    DE BONIS D; LEONI L
    Boll Soc Med Chir Cremona; 1957; 11(2):49-62. PubMed ID: 13436663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of Hydergine and the MI lytic cocktail in potentiated local anesthesia].
    DE BONIS B; LEONI L
    Boll Soc Med Chir Cremona; 1960; 14():33-40. PubMed ID: 13720416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics].
    Mercier C
    J Pharm Belg; 1982; 37(4):289-98. PubMed ID: 6754905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of a spurred rye derivative in several cases of hypertensive nephropathy].
    GERMINALE T
    Pathologica; 1957; 49(753-754):265-75. PubMed ID: 13526979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Noradrenalin and hydergine therapy of the syndrome of insufficiency of encephalic vegetative centers caused by extradural hematoma].
    SERRA P; URSO L
    Minerva Anestesiol; 1958 Apr; 24(4):168-72. PubMed ID: 13565437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proposed new durg cocktail in medical therapy of chronic obliterating arteriopathy].
    VASILE B
    Gazz Med Ital; 1958 Mar; 117(3):87-90. PubMed ID: 13538196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hydergine in hibernation].
    SCULTETY S
    Zentralbl Chir; 1957 Mar; 82(13):550-5. PubMed ID: 13434410
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydergine in anaesthesia.
    MARTIN KW
    J R Nav Med Serv; 1957; 43(3):160-1. PubMed ID: 13463903
    [No Abstract]   [Full Text] [Related]  

  • 12. Occupational toxicology of trichloroethylene with special reference to neurotoxicity.
    Juntunen J
    Dev Toxicol Environ Sci; 1986; 12():189-200. PubMed ID: 3549227
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of autonomic block (hibernation) in a rural hospital].
    SCHLAG G
    Zentralbl Chir; 1957 Dec; 82(49):2009-20. PubMed ID: 13531741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experience with neuroleptoanalgesia, type II].
    Ciocatto E; Maritano M; Pattono R
    Acta Anaesthesiol; 1965; 16():Suppl 3:51-68. PubMed ID: 5899601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peptide alkaloids of spurred rye and their semisynthetic derivatives. I. Chemistry of alkaloids (brief survey). II. Pharmacology of ergot].
    Mercier C
    J Pharm Belg; 1982; 37(3):219-27. PubMed ID: 7131229
    [No Abstract]   [Full Text] [Related]  

  • 16. Does magnesium produce anesthesia? Evaluation of its effects on the cardiovascular and neurologic systems.
    Aldrete JA; Barnes DR; Aikawa JK
    Anesth Analg; 1968; 47(4):428-33. PubMed ID: 5690534
    [No Abstract]   [Full Text] [Related]  

  • 17. [Natural and semisynthetic alkaloids of rye ergot].
    Boismare F
    LARC Med; 1981 Oct; 1(1):54, 57-8. PubMed ID: 7349678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Note on some constituents of rye ergot oil unsaponifiable].
    RUPPOL E
    J Pharm Belg; 1949; 4(3-4):55-8. PubMed ID: 18131226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rye ergot alkaloids and analogs: mechanism of action and therapeutic perspectives].
    Osswald W
    Acta Med Port; 1980; 2(2):149-59. PubMed ID: 7435232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern medication of arterial hypertension. II. Treatment with hydrogenated derivatives of ergot of rye].
    AVRIL P; BENYAMINE R
    Mars Med; 1957; 94(4):259-66. PubMed ID: 13440187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.